Costantino, H.R., et al., “Solid-Phase Aggregation of Proteins under Pharmaceutically Relevant Conditions,” Journal of Pharmaceutical Sciences, 83 (12) :1662-1669 (1994). |
Constantino, H.R., et al., “Aggregation of a Lyophilized Pharmaceutical Protein, Recombinant Human Albumin. Effect of Moisture and Stabilization by Excipients,” Biotechnology, 13:493-496 (1995). |
Liu, W.R., et al., “Moisture-Induced Aggregation of Lyophilized Proteins in the Solid State,” Biotechnology and Bioengineering, 37:177-184 (1991). |
Lu, W., et al., “Protein Release from Poly(lactic-co-glycolic acid) Microspheres: Protein Stability Problems,” PDA Journal of Pharmaceutical Science & Technology, 49 (1):13-19 (1995). |
Cleland, J.L., et al., “In Vitro Release of Bioactive Recombinant Human Interferon-γ From PLGA Microspheres,” Proceed. Intern. Symp. Control. Rel. Bioac. Mater., 22:518-519 (1995). |
Phillips, L., “Beta-Interferon: An Exciting New Agent for Multiple Sclerosis,” CPJ/RPC, 237, 240, 242 and 252 (Jun. 1994). |
Gekko, K., et al., “Compressibility-Structure Relationship of Globular Proteins,” Biochemistry, 25:6563-6571 (1986). |
Hanley, D.F., et al., “Pharmacology of Interferons I. Pharmacologic Distinctions Between Human Leukocyte and Fibroblast Interferons,” J. Immunopharmac., 1:219-226 (1979). |
Hosoi, K., et al., “Structural Characterization of Fibroblast Human Interferon-β1,” Journal of Interferon Research, 8 : 375-384 (1998). |
Rubinstein, M., “The Structure of Human Interferons,” Biochimica et Biophysica. Acta., 695:5-16 (1982). |
Yu-Chang, J.W., and Hanson, M.A., “Parenteral Formulations of Proteins and Peptides: Stability and Stabilizers,” Journal of Parenteral Science and Technology, 42 (2S):S4-S27 (1988). |
Billiau, A., et al., “Human Fibroblast Interferon for Clinical Trials: Pharmacokinetics and Tolerability in Experimental Animals and Humans,” Antimicrobial Agents and Chemotherapy, 16(1):56-63 (1979). |